Aziyo Biologics Inc. (AZYO) NASDAQ

$6.45 0 (0.00%)

Market Cap: $60.03M

As of 08/09/22 12:00 AM EDT. Market closed.

(AZYO)

Aziyo Biologics Inc. (AZYO) NASDAQ

$6.45 0 (0.00%)

Market Cap: $60.03M

As of 08/09/22 12:00 AM EDT. Market closed.

Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and ... read more

Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
163
URL
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$6.45
Days Range
$6.45 - $6.45
52 week range
$4.10 - $9.76
Volume
50
Avg. Volume (30 days)
1,646
Market Cap
$60.03M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
9,306,738
Open
$0
Previous Close
$6.45
Days Range
$6.45 - $6.45
52 week range
$4.10 - $9.76
Volume
50
Avg. Volume (30 days)
1,646
Market Cap
$60.03M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
9,306,738

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AZIYO BIOLOGICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Englese Thomas CHIEF COMMERCIAL OFFICER Dec 14, 2021 Buy $6.10 4,580 27,938 5,088 Dec 15, 2021, 04:45 PM
HighCape Capital, L.P. Director Dec 08, 2021 Buy $4.24 353,773 1,499,997 4,862,604 Dec 10, 2021, 04:22 PM
HighCape Capital, L.P. Director Dec 08, 2021 Buy $4.24 58,962 249,999 90,807 Dec 10, 2021, 04:22 PM
Ferguson Matthew CHIEF FINANCIAL OFFICER May 11, 2021 Buy $11.00 1,000 11,000 2,300 May 12, 2021, 06:01 PM
Ferguson Matthew CHIEF FINANCIAL OFFICER May 10, 2021 Buy $11.14 1,300 14,482 1,300 May 12, 2021, 06:01 PM
HighCape Capital, L.P. 10% Owner Oct 13, 2020 Option Exercise $5.44 2,451 13,339 4,067,655 Oct 13, 2020, 09:57 PM
HighCape Capital, L.P. 10% Owner Oct 13, 2020 Buy $17.00 441,176 7,499,992 4,508,831 Oct 13, 2020, 09:57 PM
HighCape Capital, L.P. 10% Owner Oct 13, 2020 Option Exercise $5.44 7,655 41,662 4,070,106 Oct 13, 2020, 09:57 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
Englese Thomas CHIEF COMMERCIAL OFFICER 12/14/2021 27,938
HighCape Capital, L.P. Director 12/08/2021 1,499,997
HighCape Capital, L.P. Director 12/08/2021 249,999
Ferguson Matthew CHIEF FINANCIAL OFFICER 05/11/2021 11,000
Ferguson Matthew CHIEF FINANCIAL OFFICER 05/10/2021 14,482
HighCape Capital, L.P. 10% Owner 10/13/2020 13,339
HighCape Capital, L.P. 10% Owner 10/13/2020 7,499,992
HighCape Capital, L.P. 10% Owner 10/13/2020 41,662
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
06/30/2021
32.72%
3Q
03/31/2022
03/31/2021
32.74%
4Q

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
32.72%
3Q
03/31/2021
32.74%
4Q